Age
Group (Years) |
No.
of. Cases |
Total
(%) |
21-30 |
340 |
33.01% |
31-40 |
407 |
39.51% |
41-50 |
178 |
17.28% |
51-60 |
80 |
7.77% |
>60 |
25 |
2.43% |
Total |
1030 |
100% |
Cytodiagnosis |
No.
of .Cases |
Percentage |
Unsatisfactory |
67 |
6.50% |
NILM Normal |
179 |
17.38% |
Inflammatory |
713 |
69.22% |
·
Nonspecific
inflammation |
685 |
66.50% |
·
Gardenella |
12 |
1.17% |
·
Trichomonas |
9 |
0.87% |
·
Candida |
7 |
0.68 |
Epithelial
cell abnormalities |
71 |
6.89% |
·
ASCUS |
27 |
2.62% |
·
AGUS |
01 |
0.10% |
·
LSIL |
25 |
2.43% |
·
HSIL |
13 |
1.26% |
·
SCC |
05 |
0.48% |
Total |
1030 |
100% |
|
21-30 |
31-40 |
41-50 |
51-60 |
>60 |
Total |
% |
ASCUS |
11 |
09 |
04 |
02 |
01 |
27 |
2.62% |
AGUS |
-- |
01 |
-- |
-- |
-- |
01 |
0.10% |
LSIL |
09 |
07 |
04 |
03 |
02 |
25 |
2.43% |
HSIL |
-- |
06 |
04 |
02 |
01 |
13 |
1.26% |
SCC |
-- |
-- |
01 |
03 |
01 |
05 |
0.48% |
Cytodiagnosis |
Present
study (n=1030) |
Kalyani
etal[17](n=1501) |
Tejaswini
etal[19] (n=210) |
Sunitha
etal[2] (n=
560) |
Unsatisfactory |
6.50% |
17.80% |
0.95% |
7.40% |
ASCUS |
2.62% |
1.46% |
2.38% |
4.00% |
AGUS |
0.10% |
0.24% |
0.48% |
00% |
LSIL |
2.43% |
0.24% |
0.95% |
1.6% |
HSIL |
1.26% |
0.41% |
1.43% |
0.4% |
SCC |
0.48% |
0.41% |
0.48% |
0.4% |